Skip Header

1 - 25 of 81 results for author:"Li L.Y." in Literature citations

Page of 4 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (103)

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution.

Wu S.J., Kuo Y.Y., Hou H.A., Li L.Y., Tseng M.H., Huang C.F., Lee F.Y., Liu M.C., Liu C.W., Lin C.T. et al.

Blood 120:3106-3111(2012) · Mapped (10)

Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.

Deng W., Gu X., Lu Y., Gu C., Zheng Y., Zhang Z., Chen L., Yao Z., Li L.Y.

Angiogenesis 15:71-85(2012) · Mapped (11)

IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression.

Liu M., Lee D.F., Chen C.T., Yen C.J., Li L.Y., Lee H.J., Chang C.J., Chang W.C., Hsu J.M., Kuo H.P. et al.

Mol. Cell 45:171-184(2012) · Mapped (9)

[Expressions of CD4+ CD25(high) regulatory T cells, TGF-beta 1 and COX-2 in the peripheral blood of prostate cancer patients].

Xia T.L., Liu T., Wu Z.Q., Zhang H.B., Yang M., Liu S.Y., He Z.B., Li L.Y.

Zhonghua Nan Ke Xue 17:888-893(2011) · Mapped (14)

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.

Ding Q., Chang C.J., Xie X., Xia W., Yang J.Y., Wang S.C., Wang Y., Xia J., Chen L., Cai C. et al.

J. Clin. Invest. 121:4526-4536(2011) · Mapped (12)

Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes.

Li L.Y., Chen H., Hsieh Y.H., Wang Y.N., Chu H.J., Chen Y.H., Chen H.Y., Chien P.J., Ma H.T., Tsai H.C. et al.

Cancer Res. 71:4269-4279(2011) · UniProtKB (3) · Mapped (7)

Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non-small cell lung cancer.

Qin L., Zhong W., Zhang L., Li L.Y., Wang M.Z.

Chin. Med. J. 124:887-891(2011) · Mapped (19)

Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.

Huang W.C., Chen Y.J., Li L.Y., Wei Y.L., Hsu S.C., Tsai S.L., Chiu P.C., Huang W.P., Wang Y.N., Chen C.H. et al.

J. Biol. Chem. 286:20558-20568(2011) · UniProtKB (1) · Mapped (28)

[Mutation screening of the F VIII gene in 10 hemophilia A families].

LI W., HU X., GAO B.D., LI L.Y., LIAO Y., TANG X.M., TANG W.L., Lu G.X.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28:127-132(2011) · Mapped (12)

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.

Hsu J.M., Chen C.T., Chou C.K., Kuo H.P., Li L.Y., Lin C.Y., Lee H.J., Wang Y.N., Liu M., Liao H.W. et al.

Nat. Cell Biol. 13:174-181(2011) · UniProtKB (2) · Mapped (18)

Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2.

Chen Y.H., Yeh F.L., Yeh S.P., Ma H.T., Hung S.C., Hung M.C., Li L.Y.

J. Biol. Chem. 286:10671-10680(2011) · Mapped (9)

CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.

Wei Y., Chen Y.H., Li L.Y., Lang J., Yeh S.P., Shi B., Yang C.C., Yang J.Y., Lin C.Y., Lai C.C. et al.

Nat. Cell Biol. 13:87-94(2011) · Mapped (9)

Overexpression of AtFRO6 in transgenic tobacco enhances ferric chelate reductase activity in leaves and increases tolerance to iron-deficiency chlorosis.

Li L.Y., Cai Q.Y., Yu D.S., Guo C.H.

Mol. Biol. Rep. 38:3605-3613(2011) · UniProtKB (1)

Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.

Song H., Li C.W., Labaff A.M., Lim S.O., Li L.Y., Kan S.F., Chen Y., Zhang K., Lang J., Xie X. et al.

Biochem. Biophys. Res. Commun. 404:68-73(2011) · Mapped (19)

Regulation of tumor angiogenesis by EZH2.

Lu C., Han H.D., Mangala L.S., Ali-Fehmi R., Newton C.S., Ozbun L., Armaiz-Pena G.N., Hu W., Stone R.L., Munkarah A. et al.

Cancer Cell 18:185-197(2010) · Mapped (6)

Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer.

Gao X., Pang J., Li L.Y., Liu W.P., Di J.M., Sun Q.P., Fang Y.Q., Liu X.P., Pu X.Y., He D. et al.

Oncogene 29:4555-4566(2010) · Mapped (5)

[Efficacy and safety of erlotinib as monotherapy for advanced non-small cell lung cancer].

Wang M.Z., Zhang X.T., Zhang X.Y., Zhang L., Zhong W., Xu L.Y., Li L.Y.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao 32:151-156(2010) · Mapped (19)

[Changes in glial fibrillary acidic protein and growth-associated protein-43 expressions in retinal ganglial cells during axonal regeneration].

Zeng Y., Wan J., Wan K., Li Y.Y., Li L.Y., Wang T.H., Feng Z.T., Jin S.X., Li Y.

Nan Fang Yi Ke Da Xue Xue Bao 30:789-792(2010) · Mapped (2)

Expression of truncated fragment of human OPG in CHO-DHFR- cells and its bioactivity characterization.

Kang B.H., Zang X.Y., Li L.Y., Zhao K.Y.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 25:1002-1004(2009) · Mapped (1)

KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.

Lee D.F., Kuo H.P., Liu M., Chou C.K., Xia W., Du Y., Shen J., Chen C.T., Huo L., Hsu M.C. et al.

Mol. Cell 36:131-140(2009) · Mapped (1)

Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.

Kuo H.P., Lee D.F., Xia W., Lai C.C., Li L.Y., Hung M.C.

Biochem. Biophys. Res. Commun. 389:156-161(2009) · Mapped (6)

The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription.

Chou C.K., Lee D.F., Sun H.L., Li L.Y., Lin C.Y., Huang W.C., Hsu J.M., Kuo H.P., Yamaguchi H., Wang Y.N. et al.

Mol. Carcinog. 48:1048-1058(2009) · Mapped (3)

Role of Neurotrophin 3 in spinal neuroplasticity in rats subjected to cord transection.

Yang H.J., Yang X.Y., Ba Y.C., Pang J.X., Meng B.L., Lin N., Li L.Y., Dong X.Y., Zhao Y., Tian C.F. et al.

Growth Factors 27:237-246(2009) · Mapped (1)

Inhibition of endothelial progenitor cell differentiation by VEGI.

Tian F., Liang P.H., Li L.Y.

Blood 113:5352-5360(2009) · Mapped (3)

Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells.

Zou H., Thomas S.M., Yan Z.W., Grandis J.R., Vogt A., Li L.Y.

FASEB J. 23:425-432(2009) · UniProtKB (1) · Mapped (26)

to top of page·

Page of 4 | Next »